CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Osteotech, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Osteotech, Inc.
51 James Way
Phone: (732) 542-2800p:732 542-2800 Eatontown, NJ  07724  United States Ticker: OSTEOSTE

This company was Merged or Acquired on 11/16/2010.
This company ceased filing statements with the SEC on 11/26/2010.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company

Business Summary
Osteotech, Inc. (Osteotech) is a technology company that develops biologic products for regenerative medicine. The Company provides biologic products for use in orthopedic, spinal, trauma, neurosurgical and oral/maxillofacial surgical procedures. It focuses its research efforts on developing biomaterials from platform technologies, such as MagniFuse, Plexur, Grafton and HCT (human collagen technology). Its legacy business lines include Grafton Technology. The Company’s products are classified in five segments: DBM Segment, Hybrid/Synthetic Segment, Traditional Tissue Segment, Spinal Allograft Segment and Client Services Segment.
(Source: 10-K)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/201012/31/2009YesYes---

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
President Christopher J.O'Connell 11/16/2010 11/16/2010
Chief Financial Officer, Vice President, Director Gary L.Ellis 11/16/2010 11/16/2010
Vice President, Controller, Director Doug A.Hoekstra 11/16/2010 11/16/2010
3 additional Officers and Directors records available in full report.

Business Names
Business Name
OST Developpement, SA
OSTE
Osteotech (S) Pte, Ltd.
TB OsteoCentre Bulgaria EAD .

General Information
Number of Employees: 297 (As of 12/31/2009)
Outstanding Shares: 18,245,363 (As of 9/20/2010)
Shareholders: 2,800
Stock Exchange: NASD
Federal Tax Id: 133357370
Fax Number: (732) 542-9312


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023